In vitro models for the prediction of in vivo performance of oral dosage forms ES Kostewicz, B Abrahamsson, M Brewster, J Brouwers, J Butler, ... European Journal of Pharmaceutical Sciences 57, 342-366, 2014 | 412 | 2014 |
A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium NH Zangenberg, A Müllertz, HG Kristensen, L Hovgaard European Journal of Pharmaceutical Sciences 14 (2), 115-122, 2001 | 361 | 2001 |
Lipid-based formulations for oral administration of poorly water-soluble drugs H Mu, R Holm, A Müllertz International journal of pharmaceutics 453 (1), 215-224, 2013 | 347 | 2013 |
New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs A Müllertz, A Ogbonna, S Ren, T Rades Journal of pharmacy and pharmacology 62 (11), 1622-1636, 2010 | 344 | 2010 |
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ... European Journal of Pharmaceutical Sciences 137, 104967, 2019 | 321 | 2019 |
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories R Hayeshi, C Hilgendorf, P Artursson, P Augustijns, B Brodin, ... European Journal of Pharmaceutical Sciences 35 (5), 383-396, 2008 | 298 | 2008 |
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs CAS Bergström, R Holm, SA Jørgensen, SBE Andersson, P Artursson, ... European Journal of Pharmaceutical Sciences 57, 173-199, 2014 | 290 | 2014 |
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a … HD Williams, P Sassene, K Kleberg, JC Bakala-N'Goma, M Calderone, ... Journal of pharmaceutical sciences 101 (9), 3360-3380, 2012 | 271 | 2012 |
A dynamic in vitro lipolysis model: II: Evaluation of the model NH Zangenberg, A Müllertz, HG Kristensen, L Hovgaard European Journal of Pharmaceutical Sciences 14 (3), 237-244, 2001 | 259 | 2001 |
Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium-and long-chain triacylglycerols JØ Christensen, K Schultz, B Mollgaard, HG Kristensen, A Mullertz European Journal of Pharmaceutical Sciences 23 (3), 287-296, 2004 | 237 | 2004 |
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS) N Thomas, R Holm, A Müllertz, T Rades Journal of controlled release 160 (1), 25-32, 2012 | 234 | 2012 |
Bile salts and their importance for drug absorption R Holm, A Müllertz, H Mu International Journal of Pharmaceutics 453 (1), 44-55, 2013 | 225 | 2013 |
Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems … R Holm, CJH Porter, GA Edwards, A Müllertz, HG Kristensen, ... European journal of pharmaceutical sciences 20 (1), 91-97, 2003 | 218 | 2003 |
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review C Stillhart, K Vučićević, P Augustijns, AW Basit, H Batchelor, TR Flanagan, ... European Journal of Pharmaceutical Sciences 147, 105280, 2020 | 213 | 2020 |
In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media VH Sunesen, BL Pedersen, HG Kristensen, A Müllertz European journal of pharmaceutical sciences 24 (4), 305-313, 2005 | 204 | 2005 |
Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state FS Nielsen, KB Petersen, A Müllertz European Journal of Pharmaceutics and Biopharmaceutics 69 (2), 553-562, 2008 | 182 | 2008 |
Bioavailability of seocalcitol: II: Development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long … M Grove, A Müllertz, JL Nielsen, GP Pedersen European journal of pharmaceutical sciences 28 (3), 233-242, 2006 | 175 | 2006 |
In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems AT Larsen, P Sassene, A Müllertz International journal of pharmaceutics 417 (1-2), 245-255, 2011 | 171 | 2011 |
A comparison of the solubility of danazol in human and simulated gastrointestinal fluids BL Pedersen, A Mullertz, H Brondsted, HG Kristensen Pharmaceutical research 17 (7), 891, 2000 | 169 | 2000 |
Clinical studies with oral lipid based formulations of poorly soluble compounds DG Fatouros, DM Karpf, FS Nielsen, A Mullertz Therapeutics and clinical risk management 3 (4), 591-604, 2007 | 164 | 2007 |